Last Updated:
Searching
Create account to add to watchlist!
Create account to add to watchlist!

Newcourt Acquisition Corp - NCAC

  • Commons

    $9.99

    +0.00%

    NCAC Vol: 0.0

  • Warrants

    $0.20

    +25.00%

    NCACW Vol: 600.0

  • Units

    $10.05

    -0.00%

    NCACU Vol: 418.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 261.4M
Average Volume: 74.2K
52W Range: $9.87 - $10.55
Weekly %: -0.10%
Monthly %: -0.30%
Inst Owners: 42

Info

Target: Searching
Days Since IPO: 214
Unit composition:
Each unit has an offering price of  $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant
Trust Size: 20000000.0M

🕵Stocktwit Mentions

Last10K posted at 2022-05-17T00:25:15Z

$NCAC just filed a 10-Q Quarterly Report with 34 sections and 4 exhibits. Access them all or just read their earnings: https://last10k.com/sec-filings/ncac/0001410578-22-001660.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=ncac

cctranscripts posted at 2022-05-16T20:39:23Z

Newcourt Acquisition Corp Just Filed Its Quarterly Report: Net Income per Ordin... https://www.conferencecalltranscripts.com/summary/?id=10856845 $NCAC

Quantisnow posted at 2022-05-16T20:27:50Z

$NCAC 📜 SEC Form 10-Q filed by Newcourt Acquisition Corp https://quantisnow.com/i/2896125?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-05-16T20:27:06Z

$NCAC Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/2c6be9d34568d429983cb9ba1e407015

Management

Officers and Directors Upon the effectiveness of the registration statement of which this prospectus forms a part, we expect that our board of directors will consist of       members. Holders of our founder shares will have the right to appoint all of our directors prior to consummation of our initial business combination and holders of our public shares will not have the right to vote on the appointment of directors during such time. These provisions of our amended and restated memorandum and articles of association may only be amended by a special resolution passed by at least 90% of our ordinary shares voting in a general meeting. Each of our directors will hold office for a two-year term. Subject to any other special rights applicable to the shareholders, any vacancies on our board of directors may be filled by the affirmative vote of a majority of the directors present and voting at the meeting of our Board or by a majority of the holders of our founder shares. Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association will provide that our officers may consist of a Chairman, Chief Executive Officer, President, Chief Financial Officer, Chief Operating Officer, Vice Presidents, Secretary, Assistant Secretaries, Treasurer and such other offices as may be determined by the board of directors. Director Independence The Nasdaq listing standards require that a majority of our board of directors be independent. An “independent director” is defined generally as a person who has no material relationship with the listed company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the company). Upon the effectiveness of the registration statement of which this prospectus forms a part, we expect to have one “independent director” as defined in the Nasdaq listing standards and applicable 115 TABLE OF CONTENTS SEC rules prior to completion of this offering. We plan to utilize the phase-in exemption under the Nasdaq rules and expect to have a majority of our board of directors to be independent within 12 months of the closing of this offering. Our board of directors has determined that Rohit Bodas is an independent director under applicable SEC and Nasdaq rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Officer and Director Compensation None of our officers or directors have received any cash compensation from us for services rendered to us. Commencing on the date that our securities are first listed on Nasdaq through the earlier of consummation of our initial business combination and our liquidation, we will pay our sponsor or its affiliate a total of $20,000 per month for office space, administrative and shared personnel support services. Our sponsor intends to allocate 15,000 founder shares to each independent director. Our sponsor, officers and directors, or entities with which they are affiliated, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or any entity with which they are affiliated. After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting, management or other fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination. It is unlikely the amount of such compensation will be known at the time such materials are distributed, because the directors of the post-combination business will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined by a compensation committee constituted solely by independent directors. We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after the initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment. Committees of the Board of Directors Upon the effective date of the registration statement of which this prospectus forms part, our board of directors will have two standing committees: an audit committee and a compensation committee. Each committee will operate under a charter that has been approved by our board and will have the composition and responsibilities described below. We will file a copy of our audit committee charter and compensation committee charter as exhibits to the registration statement of which this prospectus forms a part. Subject to phase-in rules and a limited exception, Nasdaq rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors, and Nasdaq rules require that the compensation committee of a listed company be comprised solely of independent directors. Audit Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish an audit committee of the board of directors. The initial members of our audit committee will be Mr. Bodas,         and        . Our board of directors has determined that Mr. Bodas is independent under Nasdaq listing standards and applicable SEC rules. Mr. Bodas will serve as chairman of the audit committee. We plan to utilize the phase-in exemption under Rule 10A-3 of the Exchange Act and the Nasdaq rules and expect that a majority of the members of our audit committee will satisfy the independence 116 TABLE OF CONTENTS standards promulgated by the SEC and by Nasdaq within 90 days of the closing of this offering and all members of our audit committee will satisfy the independence standards promulgated by the SEC and by Nasdaq within 12 months of the closing of this offering. Each member of the audit committee is financially literate and our board of directors has determined that Mr. Bodas qualifies as an “audit committee financial expert” as defined in applicable SEC rules. We will adopt an audit committee charter, which will detail the principal functions of the audit committee, including: • the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; ​ • pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; ​ • reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; ​ • setting clear hiring policies for employees or former employees of the independent auditors; ​ • setting clear policies for audit partner rotation in compliance with applicable laws and regulations; ​ • obtaining and reviewing a report, at least annually, from the independent auditors describing (i) the independent auditor’s internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within, the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; ​ • reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and ​ • reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. ​ Compensation Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a compensation committee of the board of directors. The members of our Compensation Committee will be Dr. Jordaan and Mr. Bodas. Mr. Bodas will serve as chairman of the compensation committee. Our board of directors have determined that Mr. Bodas is independent. We plan to utilize the phase-in exemption under the Nasdaq rules and expect that both members of our compensation committee will satisfy the independence standards promulgated by Nasdaq within 90 days of the closing of this offering. We will adopt a compensation committee charter, which will detail the principal functions of the compensation committee, including: • reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer’s based on such evaluation; ​ • reviewing and approving the compensation of all of our other officers; ​ • reviewing our executive compensation policies and plans; ​ • implementing and administering our incentive compensation equity-based remuneration plans; ​ 117 TABLE OF CONTENTS • assisting management in complying with our proxy statement and annual report disclosure requirements; ​ • approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; ​ • producing a report on executive compensation to be included in our annual proxy statement; and ​ • reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. ​ The charter will also provide that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC. Director Nominations We do not have a standing nominating committee though we intend to form a corporate governance and nominating committee as and when required to do so by law or Nasdaq rules. In accordance with Rule 5605 of the Nasdaq rules, a majority of the independent directors may recommend a director nominee for selection by the board of directors. The board of directors believes that the independent directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. The directors who will initially participate in the consideration and recommendation of director nominees are Mr. Bodas and        . Any independent directors elected in the future will also participate in the consideration and recommendation of director nominees. In accordance with Rule 5605 of the Nasdaq rules, Mr. Bodas is independent. As there is no standing nominating committee, we do not have a nominating committee charter in place. Prior to our initial business combination, the board of directors will also consider director candidates recommended for nomination by holders of our founder shares during such times as they are seeking proposed nominees to stand for appointment at an annual general meeting (or, if applicable, an extraordinary general meeting). Prior to our initial business combination, holders of our public shares will not have the right to recommend director candidates for nomination to our board. We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders. Compensation Committee Interlocks and Insider Participation None of our officers currently serves, and in the past year has not served, (i) as a member of the compensation committee or board of directors of another entity, one of whose executive officers served on our compensation committee, or (ii) as a member of the compensation committee of another entity, one of whose executive officers served on our board of directors. Code of Ethics Prior to the effectiveness of the registration statement of which this prospectus is a part, we will have adopted a Code of Ethics applicable to our directors and officers. We will file a copy of our form of Code of Ethics as an exhibit to the registration statement. You will be able to review these documents by accessing our public filings at the SEC’s web site at www.sec.gov. In addition, a copy of the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 8-K. See “Where You Can Find Additional Information.” 118 TABLE OF CONTENTS Conflicts of Interest Under Cayman Islands law, directors and officers owe the following fiduciary duties: • duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; ​ • duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; ​ • directors should not improperly fetter the exercise of future discretion; ​ • duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and ​ • duty to exercise independent judgment. ​ In addition to the above, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience which that director has. As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the amended and restated memorandum and articles of association or alternatively by shareholder approval at general meetings. Each of our directors and officers presently has, and in the future any of our directors and our officers may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present acquisition opportunities to such entity. Accordingly, subject to his or her fiduciary duties under Cayman Islands law, if any of our officers or directors becomes aware of an acquisition opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or she will need to honor his or her fiduciary or contractual obligations to present such acquisition opportunity to such entity, and only present it to us if such entity rejects the opportunity. Our amended and restated memorandum and articles of association will provide that, subject to his or her fiduciary duties under Cayman Islands law, we renounce our interest in any corporate opportunity offered to any officer or director unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue. We do not believe, however, that any fiduciary duties or contractual obligations of our directors or officers would materially undermine our ability to complete our business combination. Potential investors should also be aware of the following other potential conflicts of interest: • None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities. ​ • In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented. For a complete description of our management’s other affiliations, see “—Directors and Officers.” ​ • Each of the holders of the founder shares and placement units has agreed that his, her or its founder shares and placement shares, as applicable, will be subject to transfer restrictions and that he, she or it will not sell or transfer such shares until the applicable forfeiture provisions no longer apply. Holders of founder shares and placement shares have agreed to waive their redemption rights with respect to their founder shares and placement shares, as applicable, (i) in connection with the ​ 119 TABLE OF CONTENTS consummation of a business combination, (ii) in connection with a shareholder vote to amend our amended and restated memorandum and articles of association to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the compl

Holder Stats

1 0
% of Shares Held by All Insider 3.52%
% of Shares Held by Institutions 57.03%
% of Float Held by Institutions 59.11%
Number of Institutions Holding Shares 42

Mutual Fund Holders

Holder Shares Date Reported Value % Out
Saba Capital Income & Opportunities Fd 126219 2022-01-30 1250830 0.48
Fidelity NASDAQ Composite Index Fund 4453 2022-02-27 44262 0.02

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2022-05-17 Radcliffe Capital Management L.P. 396,240 $3,970,000 0.1% +32.1% 1.516%
2022-05-17 Saba Capital Management L.P. 1,907,917 $19,100,000 0.3% +13.6% 7.299%
2022-05-16 Goldman Sachs Group Inc. 608,435 $6,090,000 0.0% 0 2.328%
2022-05-16 Rivernorth Capital Management LLC 56,684 $570,000 0.0% 0 0.217%
2022-05-16 Aristeia Capital LLC 415,114 $4,160,000 0.1% 0 1.588%
2022-05-16 State Street Corp 15,515 $160,000 0.0% 0 0.059%
2022-05-16 Prelude Capital Management LLC 22,600 $230,000 0.0% 0 0.086%
2022-05-13 Verition Fund Management LLC 89,493 $900,000 0.0% 0 0.342%
2022-05-13 Starboard Value LP 516,222 $5,170,000 0.1% -12.3% 1.975%
2022-05-13 Basso Capital Management L.P. 118,160 $1,180,000 0.1% 0 0.452%
2022-05-13 Granby Capital Management LLC 25,000 $250,000 0.2% 0 0.096%
2022-05-12 Anson Funds Management LP 100,000 $1,000,000 0.1% 0 0.383%
2022-05-12 Bank of Montreal Can 75,000 $750,000 0.0% 0 0.287%
2022-05-11 Picton Mahoney Asset Management 300,000 $3,000,000 0.1% 0 1.148%
2022-05-11 Highbridge Capital Management LLC 892,862 $8,940,000 0.2% -42.5% 3.416%
2022-05-11 MMCAP International Inc. SPC 1,200,000 $12,010,000 0.7% +71.4% 4.591%
2022-05-09 Context Capital Management LLC 500,000 $5,010,000 0.3% 0 1.913%
2022-05-04 Wolverine Asset Management LLC 292,246 $2,930,000 0.0% -1.7% 1.118%
2022-03-15 Beryl Capital Management LLC 599,998 $5,950,000 0.3% 0 1.836%
2022-02-15 Saba Capital Management L.P. 1,678,915 $16,640,000 0.3% 0 5.138%
2022-02-15 Schonfeld Strategic Advisors LLC 100,000 $990,000 0.0% 0 0.306%
2022-02-15 Starboard Value LP 588,600 $5,830,000 0.1% 0 1.801%
2022-02-15 Marshall Wace LLP 493,270 $4,890,000 0.0% 0 1.510%
2022-02-15 Millennium Management LLC 240,000 $2,380,000 0.0% 0 0.735%
2022-02-15 Cubist Systematic Strategies LLC 161,637 $1,600,000 0.0% 0 0.495%
2022-02-14 D. E. Shaw & Co. Inc. 536,505 $5,310,000 0.0% 0 1.642%
2022-02-14 TENOR CAPITAL MANAGEMENT Co. L.P. 300,000 $2,970,000 0.1% 0 0.918%
2022-02-14 Union Square Park Capital Management LLC 100,000 $990,000 0.3% 0 0.306%
2022-02-14 Whitebox Advisors LLC 100,000 $990,000 0.0% 0 0.306%
2022-02-14 CSS LLC IL 453,029 $4,490,000 0.2% 0 1.386%
2022-02-14 Radcliffe Capital Management L.P. 300,000 $2,970,000 0.1% 0 0.918%
2022-02-14 Taconic Capital Advisors LP 500,000 $4,950,000 0.2% 0 1.530%
2022-02-09 MMCAP International Inc. SPC 700,000 $6,940,000 0.4% 0 2.142%
2022-02-09 Wolverine Asset Management LLC 297,400 $2,950,000 0.0% 0 0.910%